Diamonds and Dogs


Boeing (BA) flying higher. The worst performing Dow component for the year is now helping prop up the Dow with a 5% rally to levels not seen since December. The company easily beat earnings estimates by 20 cents as sales fell 7.5% year over year to $23.9 billion. Investors seem to be looking toward 2017 when business is expected to pick back up. During the quarter, the Boeing paid $700 million in dividends and repurchased 51 million shares for a total of $6.5 billion or 7% of their market cap. Wow. The analyst at Standpoint downgraded the stock to a sell and a $125 price target before the open. Thanks for nothing.


Edwards Lifesciences (EW) takes a hit. The heart value maker saw sales rise 20.1% year over year, great for most companies, but not for Edwards Lifesciences. The stock is down 16% back to the June lows. Management still thinks it can hit the high end of its previous revenue guidance of $2.7 billion to $3.0 billion, but the company is limited to the number of patients requiring such heart valve surgeries particularly for long term growth. I guess this is a good thing for the average person.

Diamonds and Dogs market commentary is a journal of daily observations on anything that happens to be of interest to our author. Obviously, our primary focus is the stock market and world economic events, but for this page we have no defined topics. We want this page to be dedicated to the interests, concerns, and possibly to the financial gain of our clients and friends. All comments contained herein are for informational purposes only, and should not be considered as a solicitation to buy or sell any security. The firm does not guarantee the accuracy or completeness of the information or make any warranties regarding results from it's usage.